A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period

Trial Profile

A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Jan 2017

At a glance

  • Drugs Anastrozole/levonorgestrel (Primary) ; Leuprorelin; Levonorgestrel
  • Indications Endometriosis
  • Focus Proof of concept; Therapeutic Use
  • Acronyms ESPARIOS 1
  • Sponsors Bayer
  • Most Recent Events

    • 02 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 12 Oct 2016 This trial was suspended in Denmark, according to European Clinical Trials Database.
    • 31 Aug 2016 This trial has been completed in Austria as per European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top